论文信息 - Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study - 字舞流文

Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study

W. Ai | T. Feldman | M. Lechowicz | C. Okada | D. Jagadeesh | J. Alderuccio | A. Huen | B. Haverkos | A. Mohrbacher | P. Ghione | Seo-hyun Kim | P. Barde | S. Iyer | A. Nair | K. Routhu | R. Champion